Factory Free sample COVID-19 antigen test - Fungus (1-3)-β-D-Glucan Test (Chromogenic Method) – Genobio

Product Introduction

FungiXpert® Fungus (1-3)-β-D-Glucan Detection Kit (Chromogenic Method) is intended for the screening diagnosis of invasive fungal disease. It is used to provide rapid diagnostic reference for clinical invasive fungal infections through quantitative detection of (1-3)-β-D-glucan in the serum and Bronchoalveolar Lavage (BAL) fluid. GCT-110T series are intended for manual operation with microplate reader. GKT-5M/10M are used with our semi-automated instrument MB80 series and fully automated instrument IGL series.

Characteristics

Advantages

• Methodology advantages
  Obtain results in 40-60 min, 5-8 days prior to clinical symptoms and imaging
  Recommended by the EORTC/MSG Consensus Group as one of the mycological criteria for the diagnosis of invasive fungal disease
• More options available:
  Automated instruments / Manual operation
  Larger / smaller throughput
  Customization service
• Quality controls are provided with the kit
  More reliable experimental accuracy

• Compatible with Automatic instruments
  Can be equipped with fully automatic instruments, easy and reduce errors
  Fully Automatic Kinetic Tube Reader (IGL-200)
  Fully Automatic Kinetic Tube Reader (IGL-800)
  Kinetic Tube Reader (MB-80M)
  Kinetic Tube Reader (MB-80A)
  Kinetic Tube Reader (MB-80X)
• Good manufacture quality and ability
  Total manufacture from principal raw materials to finished products.
  In 2017, Era Biology, as a leader and pioneer in the industry, participated in drafting the industry standard of “Fungus（1-3）-B-D-Glucan Test” with National Center for Clinical Laboratories etc.

Principle of BDG test

Fungus (1-3)-B-D-Glucan (BDG) is a unique element of fungal cell wall, when the fungus invades blood or deep tissue, BDG can be released from the cell wall.

Applicable departments

Order Information